Under the collaboration agreement, Radiopharmacus will gain exclusive rights to manufacture and sell Cell>Point products in Brazil, and also provide a range of services such as commercial scale
Under the agreement, Ergomed will be conducting the first clinical trials for one of Hikma’s key oncology (anti-cancer) products in Jordanian hospitals with plans of potential expansion in
The randomized, active-controlled, open-label trial is designed to enroll at 8 US clinical centers up to 45 patients with Parkinson’s disease with motor fluctuations. The crossover study will
According to the company, AML program has the potential to produce multiple drug candidates with differing activity profiles that can be used to treat acute leukemias with different
Developed by Genoscience professor Philippe Halfon , BL-8020 acts by inhibiting Hepatitis C virus (HCV)-induced autophagy, which differs from the mechanism of currently used anti-HCV agents. The pre-clinical
Oramed’s core product is an oral insulin capsule. An oral delivery system for insulin may increase patient value, leading to a healthier lifestyle, the company said. Higher patient
OPKO will acquire ALS for $4m in an all cash transaction from Inversiones SVJV, Inversiones BS and Inversiones PYTT. ALS is an exclusive product distributor of Arama Laboratorios.
The OPKO test panel will combine PSA and two novel kallikrein markers to provide greater accuracy. The biomarkers were developed by investigators at the University of Malmo, Sweden,
Inhaled nitric oxide is available as Inomax for inhalation, which, in combination with ventilation and other appropriate agents, treats term and near-term newborns with hypoxic respiratory failure associated
The new solution will add support for GS1 standards, including GS1 barcodes, data standards, and the EPCIS interface standard. The VB Enterprise 4.0 UID procurement service will give
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.